Adalimumab as a second-line biological therapy in children with refractory ulcerative colitis. [electronic resource]
Producer: 20160815Description: 1425-8 p. digitalISSN:- 1473-5687
- Adalimumab -- administration & dosage
- Adolescent
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Child
- Colectomy
- Colitis, Ulcerative -- drug therapy
- Drug Administration Schedule
- Drug Evaluation -- methods
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Infliximab -- therapeutic use
- Male
- Remission Induction
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.